ABEONA THERAPEUTICS INC. (ABEO) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 212 transactions totaling $9.5M, demonstrating a bearish sentiment with -$6.0M in net insider flow. The most recent transaction on Feb 2, 2026 involved a sale of 16,284 shares valued at $82.9K.
No significant insider buying has been recorded for ABEO in the recent period.
No significant insider selling has been recorded for ABEO in the recent period.
Based on recent SEC filings, insider sentiment for ABEO is bearish with an Insider Alignment Score of 19/100 and a net flow of -$6.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ABEONA THERAPEUTICS INC. (ABEO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading ABEO stock, having executed 212 transactions in the past 90 days. The most active insider is Steven H. Rouhandeh (Executive), who has made 13 transactions totaling $2.1M.
Get notified when executives and directors at ABEO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Crombez Eric | Executive | Sale | 16,284 | $5.09 | $82.9K | |
| Feb 2, 2026 | A. Wuchterl Donald | Executive | Sale | 14,814 | $5.09 | $75.4K | |
| Jan 22, 2026 | M. O'malley Brendan | SVP, Chief Legal Officer | Sale | 13,578 | $5.33 | $72.4K | |
| Jan 22, 2026 | Seshadri Vishwas | Executive | Sale | 69,832 | $5.33 | $372.3K | |
| Jan 22, 2026 | Walter Vazzano Joseph | Chief Financial Officer | Sale | 18,666 | $5.33 | $99.5K | C-Suite |
| Jan 20, 2026 | Seshadri Vishwas | Executive | Award | 365,422 | $N/A | $0 | |
| Jan 20, 2026 | Walter Vazzano Joseph | Chief Financial Officer | Award | 133,595 | $N/A | $0 | C-Suite |
| Dec 29, 2025 | Seshadri Vishwas | Executive | Sale | 25,000 | $5.31 | $132.7K | |
| Dec 29, 2025 | Seshadri Vishwas | Executive | Sale | 25,000 | $5.31 | $132.8K | |
| Nov 13, 2025 | Alvino Mark | Executive | Sale | 15,000 | $4.74 | $71.1K | |
| Oct 16, 2025 | Seshadri Vishwas | Executive | Sale | 249 | $5.49 | $1.4K | |
| Sep 30, 2025 | Seshadri Vishwas | Executive | Sale | 25,000 | $5.24 | $131.0K | |
| Sep 29, 2025 | Walter Vazzano Joseph | Executive | Sale | 9,035 | $5.39 | $48.7K | |
| Sep 29, 2025 | Seshadri Vishwas | Executive | Sale | 19,274 | $5.39 | $103.9K | |
| Sep 29, 2025 | M. O'malley Brendan | Executive | Sale | 9,366 | $5.39 | $50.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 74 | $7.8M | 61.6% |
Purchase(P) | 21 | $1.8M | 14.0% |
Award(A) | 80 | $1.6M | 12.9% |
Exercise(M) | 10 | $816.1K | 6.5% |
Payment(F) | 25 | $635.5K | 5.0% |
Disposition(D) | 2 | $0 | 0.0% |
Insider selling pressure at ABEONA THERAPEUTICS INC. has increased, with 25 insiders executing 212 transactions across all time. Total sales of $7.8M significantly outpace purchases of $1.8M, resulting in a net outflow of $6.0M. This selling activity appears largely discretionary, which may warrant closer attention from investors.